# Vasopressin and Pain Perception in the Brain

> **NCT03446456** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 40 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Arginine vasopressin
- **OTHER:** Saline
- **BEHAVIORAL:** Observational learning
- **OTHER:** fMRI data aquisition

## Key facts

- **NCT ID:** NCT03446456
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-09-17
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03446456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03446456, "Vasopressin and Pain Perception in the Brain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03446456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
